Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study
AUTOR(ES)
Bolli, Geremia B.
FONTE
American Diabetes Association
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2699706Documentos Relacionados
- Once-daily aminoglycoside therapy.
- Once-daily aminoglycoside therapy: potential ototoxicity.
- Once-daily aminoglycoside therapy: potential ototoxicity.
- Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy
- Real-World Outcomes of Once-Daily Risperidone Dosing
